Pilot Phase II, Randomized , and Control in Double Blind Placebo Effectiveness a 3 Months on Bleeding Fibroids Treatment With ULIPRISTAL ACETATE 10 mg/Day in Patients Suffering From Symptomatic Endometriosis
Phase of Trial: Phase II
Latest Information Update: 24 Mar 2017
At a glance
- Drugs Ulipristal (Primary)
- Indications Adenomyosis
- Focus Therapeutic Use
- Acronyms FRA-IIT-UPA
- 23 Nov 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Jun 2017.
- 08 Apr 2016 Planned End Date changed from 1 Nov 2016 to 1 Nov 2017, according to ClinicalTrials.gov record.
- 08 Apr 2016 Planned primary completion date changed from 1 Feb 2016 to 1 Dec 2016, according to ClinicalTrials.gov record.